Proximal tubules of the kidney are responsible for the reabsorption of both 90% of the filtered load of bicarbonate and 70% of the filtered fluid. Both of these processes are interrelated. Recent developmnet of methods for measuring bicarbonate concentrations in small volumes has allowed for accurate evaluation of bicarbonate transport in the setting of micropuncture and in vitro microperfusion. The latter method, because it allows for greater control of the acid-base status of the tubule environment and because it allows for examination of nephron segments not accessible to micropuncture, is well suited for detailed investigations of the regulatory influences of acid-base changes on proximal tubule transport. The studies proposed in this application have three major goals: First, to examine the mechanism by which renal proximal tubules reabsorb bicarbonate; second, to examine various regulatory influences on bicarbonate reabsorption; and third, to determine the relationships between bicarbonate reabsorption, net volume reabsorption, the reabsorption of sodium, chloride, phosphate, and various organic solutes. Proximal tubule segments from rabbits will be perfused in vitro and standard microperfusion methods will be supplemented by microelectrode measurements of intracellular voltage and pH. This combination of techniques will allow for analysis not only of transepithelial events, but also of transport events occurring across the luminal and peritubular cell membranes. Thus the effects of bicarbonate concentration, pH, pCO2, potassium, and peritubular oncotic pressure on proximal tubule bicarbonate and volume reabsorption can be examined in detail previously not possible. The results of these studies are expected to provide major new information on the mechanisms and regulation of proximal tubule function.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK037097-03
Application #
3235807
Study Section
General Medicine B Study Section (GMB)
Project Start
1985-08-01
Project End
1988-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
3
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Robb, Calum T; McSorley, Henry J; Lee, Jinju et al. (2018) Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis. J Allergy Clin Immunol 141:152-162
Kong, Deping; Li, Juanjuan; Shen, Yujun et al. (2017) Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D2 Receptor Subtype 1. J Pharmacol Exp Ther 360:435-444
Duffin, Rodger; O'Connor, Richard A; Crittenden, Siobhan et al. (2016) Prostaglandin E? constrains systemic inflammation through an innate lymphoid cell-IL-22 axis. Science 351:1333-8
Kraemer, Maria P; Choi, Hyehun; Reese, Jeff et al. (2016) Regulation of arterial reactivity by concurrent signaling through the E-prostanoid receptor 3 and angiotensin receptor 1. Vascul Pharmacol 84:47-54
Kong, Deping; Shen, Yujun; Liu, Guizhu et al. (2016) PKA regulatory II? subunit is essential for PGD2-mediated resolution of inflammation. J Exp Med 213:2209-26
Ceddia, Ryan P; Lee, DaeKee; Maulis, Matthew F et al. (2016) The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice. Endocrinology 157:220-32
Oishi, Yo; Yoshida, Kyoko; Scammell, Thomas E et al. (2015) The roles of prostaglandin E2 and D2 in lipopolysaccharide-mediated changes in sleep. Brain Behav Immun 47:172-7
Hoggatt, Jonathan; Mohammad, Khalid S; Singh, Pratibha et al. (2013) Differential stem- and progenitor-cell trafficking by prostaglandin E2. Nature 495:365-9
Natarajan, Chandramohan; Hata, Aaron N; Hamm, Heidi E et al. (2013) Extracellular loop II modulates GTP sensitivity of the prostaglandin EP3 receptor. Mol Pharmacol 83:206-16
Downey, Jason D; Saleh, Sam A; Bridges, Thomas M et al. (2013) Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostere. Bioorg Med Chem Lett 23:37-41

Showing the most recent 10 out of 90 publications